RA CAPITAL MANAGEMENT, L.P. Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$5.5B
Holdings
70
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (70 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 5,909,742 | $912.0B | 16681.04% | |
| 2 | —FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $449.1B | 8215.15% | |
| 3 | CCXIEURCHEMOCENTRYX INC | 4,826,910 | $264.5B | 4838.19% | |
| 4 | PCVXVAXCYTE INC | 5,283,818 | $260.9B | 4772.34% | |
| 5 | TGTXTG THERAPEUTICS INC | 8,825,849 | $236.2B | 4319.92% | |
| 6 | NKTXNKARTA INC | 5,605,129 | $168.5B | 3081.82% | |
| 7 | AXSMAXSOME THERAPEUTICS INC | 2,035,132 | $145.0B | 2652.22% | |
| 8 | PHATPHATHOM PHARMACEUTICALS INC | 3,825,008 | $140.3B | 2565.52% | |
| 9 | MCRB1EURSERES THERAPEUTICS INC | 4,750,000 | $134.5B | 2459.62% | |
| 10 | NVV1NOVAVAX INC | 1,198,602 | $129.9B | 2375.41% | |
| 11 | ETNBGBP89BIO INC | 4,736,214 | $121.5B | 2222.90% | |
| 12 | RYTMRHYTHM PHARMACEUTICALS INC | 5,140,408 | $111.4B | 2037.47% | |
| 13 | MGNXMACROGENICS INC | 4,375,217 | $110.2B | 2015.87% | |
| 14 | —EIDOS THERAPEUTICS INC | 2,163,271 | $109.3B | 1999.37% | |
| 15 | 5E7ITEOS THERAPEUTICS INC | 4,417,258 | $109.0B | 1993.22% | |
| 16 | —ZOGENIX INC | 5,488,424 | $98.4B | 1799.94% | |
| 17 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 9,410,860 | $96.9B | 1772.96% | |
| 18 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 11,329,581 | $90.4B | 1653.67% | |
| 19 | TREURTRILLIUM THERAPEUTICS INC | 6,162,694 | $87.6B | 1601.76% | |
| 20 | ARVNARVINAS INC | 3,672,872 | $86.7B | 1586.12% | |
| 21 | —RETROPHIN INC | 4,635,687 | $85.6B | 1565.23% | |
| 22 | KALAKALA PHARMACEUTICALS INC | 10,874,613 | $81.6B | 1491.80% | |
| 23 | BDTXBLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $78.3B | 1432.04% | |
| 24 | LEGNLEGEND BIOTECH CORP | 2,408,292 | $74.3B | 1359.81% | |
| 25 | 1K0IGM BIOSCIENCES INC | 982,723 | $72.5B | 1326.72% | |
| 26 | KROSKEROS THERAPEUTICS INC | 1,875,000 | $72.3B | 1322.77% | |
| 27 | VXRTVAXART INC | 10,810,937 | $71.9B | 1314.98% | |
| 28 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $66.0B | 1207.41% | |
| 29 | PMVPPMV PHARMACEUTICALS INC | 1,710,265 | $60.7B | 1110.51% | |
| 30 | DYNDYNE THERAPEUTICS INC | 2,805,045 | $56.6B | 1035.88% | |
| 31 | INZYINOZYME PHARMA INC | 2,003,653 | $52.7B | 963.49% | |
| 32 | GONGERON CORP | 30,126,299 | $52.4B | 958.80% | |
| 33 | —AKOUOS INC | 2,281,249 | $52.2B | 954.27% | |
| 34 | ORTXUSDORCHARD THERAPEUTICS PLC | 12,315,213 | $50.6B | 925.81% | |
| 35 | CRDFCARDIFF ONCOLOGY INC | 3,290,000 | $46.7B | 853.91% | |
| 36 | RLAYRELAY THERAPEUTICS INC | 1,000,000 | $42.6B | 779.00% | |
| 37 | INBXUSDINHIBRX INC | 2,129,003 | $38.3B | 700.94% | |
| 38 | ALECALECTOR INC | 3,618,748 | $38.1B | 697.32% | |
| 39 | CRNXCRINETICS PHARMACEUTICALS INC | 2,328,698 | $36.5B | 667.45% | |
| 40 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,165,184 | $34.1B | 624.45% | |
| 41 | ARDXARDELYX INC | 6,260,904 | $32.9B | 601.22% | |
| 42 | VRNAVERONA PHARMA PLC | 5,100,000 | $31.8B | 582.09% | |
| 43 | RLMDRELMADA THERAPEUTICS INC | 781,290 | $29.4B | 537.60% | |
| 44 | SCPHSCPHARMACEUTICALS INC | 3,518,998 | $26.2B | 479.53% | |
| 45 | IMGNEURIMMUNOGEN INC | 7,040,485 | $25.3B | 463.60% | |
| 46 | LRMRLARIMAR THERAPEUTICS INC | 1,515,151 | $23.0B | 420.41% | |
| 47 | STROSUTRO BIOPHARMA INC | 2,118,212 | $21.3B | 389.37% | |
| 48 | OCULOCULAR THERAPEUTIX INC | 2,727,272 | $20.8B | 379.63% | |
| 49 | —PANDION THERAPEUTICS INC | 1,770,023 | $20.3B | 371.01% | |
| 50 | —PREVAIL THERAPEUTICS INC | 1,915,568 | $19.5B | 356.67% | |
| 51 | CNCEEURCONCERT PHARMACEUTICALS INC | 1,858,474 | $18.3B | 333.81% | |
| 52 | —SATSUMA PHARMACEUTICALS INC | 4,681,858 | $18.2B | 333.11% | |
| 53 | MISTMILESTONE PHARMACEUTICALS INC | 2,418,798 | $17.7B | 323.86% | |
| 54 | SNDXSYNDAX PHARMACEUTICALS INC | 1,023,067 | $15.1B | 276.19% | |
| 55 | —BCTG ACQUISITION CORP | 1,250,000 | $12.9B | 236.87% | |
| 56 | RPTXREPARE THERAPEUTICS INC | 409,000 | $12.6B | 230.19% | |
| 57 | —FS DEV CORP | 1,000,000 | $11.2B | 204.82% | |
| 58 | —ARYA SCIENCES ACQUISITION CO | 1,000,000 | $10.8B | 197.81% | |
| 59 | VSTMVERASTEM INC | 8,066,171 | $9.8B | 178.52% | |
| 60 | SLDBSOLID BIOSCIENCES INC | 4,571,164 | $9.3B | 169.72% | |
| 61 | LYRALYRA THERAPEUTICS INC | 815,849 | $9.3B | 169.23% | |
| 62 | —ARYA SCIENCES ACQUISITION CORP | 700,000 | $7.7B | 140.84% | |
| 63 | GRTXGALERA THERAPEUTICS INC | 825,118 | $7.5B | 136.43% | |
| 64 | —HEALTH SCIENCES ACQ CORP 2 | 625,000 | $6.9B | 125.75% | |
| 65 | TCE2CELLDEX THERAPEUTICS INC NEW | 353,072 | $5.2B | 95.77% | |
| 66 | —IMARA INC | 249,739 | $5.1B | 92.92% | |
| 67 | PASGPASSAGE BIO INC | 322,630 | $4.2B | 77.37% | |
| 68 | ASNSUSDX4 PHARMACEUTICALS INC | 559,494 | $3.8B | 69.29% | |
| 69 | EPIEURESSA PHARMA INC | 470,428 | $3.2B | 59.37% | |
| 70 | OVIDOVID THERAPEUTICS INC | 285,000 | $1.6B | 29.92% |